Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae. - Wikidata - awgldk - TriplyDB

Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae.

Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae.

http://www.wikidata.org/entity/Q46577790

about

Characterization of a distinct host response profile to Pneumocystis murina asci during clearance of pneumocystis pneumonia Recent advances in the management of mucormycosis: from bench to bedside Echinocandin treatment of pneumocystis pneumonia in rodent models depletes cysts leaving trophic burdens that cannot transmit the infection Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment Characterization of Scedosporium apiospermum glucosylceramides and their involvement in fungal development and macrophage functions Innate immunity to Aspergillus species.Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection.Aspergillus galactosaminogalactan mediates adherence to host constituents and conceals hyphal β-glucan from the immune system.Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination.PrtT-regulated proteins secreted by Aspergillus fumigatus activate MAPK signaling in exposed A549 lung cells leading to necrotic cell death.Fungal infections in transplant and oncology patients.Endoplasmic reticulum localized PerA is required for cell wall integrity, azole drug resistance, and virulence in Aspergillus fumigatus.Breakthrough invasive candidiasis in patients on micafungin.Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents.The Aspergillus fumigatus cspA gene encoding a repeat-rich cell wall protein is important for normal conidial cell wall architecture and interaction with host cells DL-2-hydroxyisocaproic acid attenuates inflammatory responses in a murine Candida albicans biofilm model.Dectin-1: a role in antifungal defense and consequences of genetic polymorphisms in humans.Protective effects of surfactant protein D treatment in 1,3-β-glucan-modulated allergic inflammation.Micafungin in the treatment of invasive candidiasis and invasive aspergillosis Candida albicans infections in renal transplant recipients: effect of caspofungin on polymorphonuclear cells Differences in efficacy and cytokine profiles following echinocandin or liposomal amphotericin B monotherapy or combination therapy for murine pulmonary or systemic Aspergillus flavus infections Future directions in mucormycosis research.Role of innate immune receptors in paradoxical caspofungin activity in vivo in preclinical aspergillosis.Micafungin Elicits an Immunomodulatory Effect in Galleria mellonella and Mice.Invasive fungal infections in acute leukemia.Albumin Enhances Caspofungin Activity against Aspergillus Species by Facilitating Drug Delivery to Germinating Hyphae.Nanoscopic cell-wall architecture of an immunogenic ligand in Candida albicans during antifungal drug treatment.Hypoxia enhances innate immune activation to Aspergillus fumigatus through cell wall modulation.Stage-specific innate immune recognition of Aspergillus fumigatus and modulation by echinocandin drugs.Impact of in vivo triazole and echinocandin combination therapy for invasive pulmonary aspergillosis: enhanced efficacy against Cyp51 mutant isolates Deletion of the α-(1,3)-glucan synthase genes induces a restructuring of the conidial cell wall responsible for the avirulence of Aspergillus fumigatus.Impaired bactericidal but not fungicidal activity of polymorphonuclear neutrophils in patients with chronic lymphocytic leukemia.Pattern recognition: recent insights from Dectin-1 Aspergillus fumigatus: cell wall polysaccharides, their biosynthesis and organization.Immunotherapy for opportunistic infections: Current status and future perspectives.Current perspectives on echinocandin class drugs.Invasive fungal infections in the ICU.Echinocandin pharmacodynamics: review and clinical implications.Use of posaconazole in the treatment of invasive fungal infections.Antifungal prophylaxis and therapy in patients with hematological malignancies and hematopoietic stem cell transplant recipients.

P2860

Q24614334-5BE65BF8-EDE9-45C3-9221-7438725B3D94 Q24642450-95C27BE7-5F5F-444B-A00D-7A1C3C198179 Q28472713-9548FA96-0965-419C-A307-411F6945FCBA Q28474181-9AFEAEC9-1B78-4ADC-96C9-5F51A4843EB3 Q28539197-E87FBE00-281F-483E-83F3-13FCCE6AB660 Q30434628-9EA57F34-7CEB-48D7-BF48-CDB7C002AB56 Q30585324-AAC3C714-7894-4645-A22B-E650DABAA811 Q31129835-20751EE0-F6B8-4EA3-91A0-49134DD52BE4 Q33490772-4D1F1ECC-3AFE-4124-A3F8-C32F6E17FF5B Q33848942-D493E274-CBAF-49F3-8559-8130A20DBA0F Q33896940-840EBAF3-F3D5-42D5-BF3F-BA59A4BEFAAA Q33956119-175D8118-5591-400A-97AA-84360703EA87 Q33963538-D17B8C62-A9CE-4E70-A35F-3CB3EDCF6656 Q34024546-A7FD93EE-68C1-46B9-8515-56FB7F084DD9 Q34118934-093E249F-B61B-4E66-B0D8-F16C3631431B Q34260729-6B19D774-23C3-4854-89E1-9159D17607C9 Q34520982-43C1717E-3A30-4F2A-ADC9-1F0B5087F041 Q34673568-DB135F6E-1F3A-4D38-8BDC-A368F2E3F9ED Q35026516-1D25A0D9-F42F-49F9-8AD1-013619C8540D Q35598563-2EC2F45A-68AE-4217-A87F-7255636EC158 Q35666612-C47CCDE3-1E05-436A-9097-B8C03644BEE4 Q35672102-30EEBB3C-CB54-42A3-9246-EC92B7600A1C Q36171611-B9FC8860-EEDE-4E0D-9ED0-66AFFE8AB3E0 Q36365889-8EA37D57-4BDD-4085-BB2E-701ECD8E1366 Q36612597-DFCB9698-10B7-40C4-9D3C-7CBA6C8A93FC Q36644611-AF84908B-9521-4D5A-A10C-5D54735212F0 Q36685105-E3FD22E8-E2E6-4633-9127-02C0EBAC81A9 Q37045301-E80AED7B-827D-459B-8E9D-1847833C1EC9 Q37209970-ABFF0497-ECBC-4D3F-9619-8BC294918029 Q37263430-0C71868C-9B78-4A2C-95A4-E25D056736B0 Q37308743-B36828A4-BFDD-45CC-B453-24D8790B3A57 Q37382813-FB4D913A-8AF6-43D9-9403-468146411728 Q37395165-C3ECED60-0E07-4218-99C0-6CF5A2BD27AA Q37506518-F8766CF6-7595-4FC6-8800-129016B2F210 Q37509216-2B5CA353-1D06-484A-80A7-E874E1F55E8F Q37554055-B6724833-C43D-4D67-9DA9-8BBD2540786A Q37643057-4940282F-DADE-453D-94AA-701B15172035 Q37718385-94D9FA2B-8A83-4E7A-8700-88F83A8D5392 Q37810083-26BF3336-3377-4752-9003-B49A54E81CC0 Q37816399-8FABB521-B335-4FB2-9A8A-320F6EC4FF56

P2860

Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae.

http://www.wikidata.org/entity/Q46577790

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Caspofungin-mediated beta-gluc ...... us and non-Aspergillus hyphae.

@en

Caspofungin-mediated beta-gluc ...... us and non-Aspergillus hyphae.

@nl

type

label

Caspofungin-mediated beta-gluc ...... us and non-Aspergillus hyphae.

@en

Caspofungin-mediated beta-gluc ...... us and non-Aspergillus hyphae.

@nl

prefLabel

Caspofungin-mediated beta-gluc ...... us and non-Aspergillus hyphae.

@en

Caspofungin-mediated beta-gluc ...... us and non-Aspergillus hyphae.

@nl

P1433

Q46577790-C9CE818E-69B3-4AC7-BC5B-29FA2E9CAFED

P1476

Q46577790-250ADF77-FAB8-428A-9698-3E07DDF5BEFC

P2093

Q46577790-31F0204E-1B8D-40B4-92A5-4E9CE85CB1A3

Q46577790-4A32CA19-75EF-47D1-8E36-3E2E537AAB41

Q46577790-80268E88-BD5C-4ED4-888B-DAAB16E5E854

Q46577790-923328E8-B8A4-459C-8844-52D112AE55EF

Q46577790-A81F587A-CBFA-40B7-9381-3D2F671AFAD0

Q46577790-BEEE54F5-0D06-4410-AA20-6D5116E86EBE

Q46577790-C2D04458-9D85-43F9-A94C-F5A1DD7B8E38

P2860

Q46577790-05AEBB47-E5FA-41D7-B89F-51F6E90AF91E

Q46577790-15085C3B-F69E-4E0A-A760-B5F61E6A31E5

Q46577790-1D08181D-B5BC-48E8-A1AB-E0A41DD01EA1

Q46577790-1EB876C2-0003-44B2-ADF9-DDB3B895F423

Q46577790-227F0CA5-7D33-484C-9CFC-947E0F20AAA3

Q46577790-2550F89E-951F-4A2E-81EB-5C2A3BB3C5BA

Q46577790-362A82EC-775F-4A30-B6CA-16EF986D25AC

Q46577790-5D16C7F0-7652-476E-8BCD-F9FBF7C465A0

Q46577790-60D70717-2D3D-40C4-9A16-0820BCBE4B8D

Q46577790-6177BB40-3D61-4D1E-A512-852C71C435D2

P304

Q46577790-CD16EBD4-A953-42E7-A63F-8FA1A7E51588

P31

Q46577790-6177B58F-A56F-4A07-A537-1DB9E8F1B081

P356

Q46577790-3B1C7738-B0EA-4E21-B4F1-2EF5D0972FC3

P407

Q46577790-AF580D95-5E71-4EA7-868E-7BC163EF5BCA

P433

Q46577790-E998C8C1-35A4-493B-9A01-3E30003ADB55

P478

Q46577790-131F88AB-46B4-49B6-AD8C-D506E4F220DF

P50

Q46577790-3AF57A67-512E-4353-AF85-0A24CB827C10

P577

Q46577790-5C262292-D5DA-48AA-B9A6-1139007DF65F

P5875

Q46577790-69ED496E-6EEC-4E3D-A416-FEB7EB1D4189

P698

Q46577790-B9B36C2A-2E67-4449-810E-F0F9570CE643

P356

P1433

The Journal of Infectious Diseases

P1476

Caspofungin-mediated beta-gluc ...... us and non-Aspergillus hyphae.

@en

P2093

Amar Safdar

http://www.w3.org/2001/XMLSchema#string

Dimitrios P Kontoyiannis

http://www.w3.org/2001/XMLSchema#string

Georgios Chamilos

http://www.w3.org/2001/XMLSchema#string

Gregory A Lamaris

http://www.w3.org/2001/XMLSchema#string

Gregory S May

http://www.w3.org/2001/XMLSchema#string

Issam I Raad

http://www.w3.org/2001/XMLSchema#string

Thomas J Walsh

http://www.w3.org/2001/XMLSchema#string

P2860

Immune recognition. A new receptor for beta-glucans

Dectin-1: a signalling non-TLR pattern-recognition receptor

Dectin-1 mediates the biological effects of beta-glucans

Echinocandin antifungal drugs

Innate immunity to the pathogenic fungus Coccidioides posadasii is dependent on Toll-like receptor 2 and Dectin-1.

Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis.

Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments.

Invasive aspergillosis in 2002: an update.

Impact of current transplantation practices on the changing epidemiology of infections in transplant recipients.

Immunity to fungal infections.

P304

186-192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/589305

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

198

http://www.w3.org/2001/XMLSchema#string

P50

Russell E. Lewis

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5349145

http://www.w3.org/2001/XMLSchema#string

P698

18500936

http://www.w3.org/2001/XMLSchema#string